Ian Lipkin

Dr. Ian Lipkin


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2007 in Science
Verified
Journal Article
Closed access
PDF file
DCDiana L. Cox-Foster
Diana L. Cox-Foster
SCSean Conlan
Sean Conlan
EHEdward Holmes
Edward Holmes
GPGustavo Palacios
Gustavo Palacios
Jay EvansJay Evans
Jay Evans
ILIan Lipkin
Ian Lipkin
In colony collapse disorder (CCD), honey bee colonies inexplicably lose their workers. CCD has resulted in a loss of 50 to 90% of colonies in beekeeping operations across the United States. The observation that irradiated combs from affected colonies can be repopulated with naive bees suggests that infection may contribute to CCD. We used an unbiased metagenomic approach to survey microflora in CCD hives, normal hives, and imported royal jelly. Candidate pathogens were screened for significance of association with CCD by the examination of samples collected from several sites over a period of 3 years. One organism, Israeli acute paralysis virus of bees, was strongly correlated with CCD.

1 December 2012 in The Lancet
Verified
Journal Article
Closed access
SMStephen S Morse
Stephen S Morse
JMJonna Ak Mazet
Jonna Ak Mazet
MWMark Woolhouse
Mark Woolhouse
CPColin R Parrish
Colin R Parrish
DCDennis Carroll
Dennis Carroll
PDPeter Daszak
Peter Daszak

10 January 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JWJens Wrammert
Jens Wrammert
DKDimitrios Koutsonanos
Dimitrios Koutsonanos
GLGui-Mei Li
Gui-Mei Li
SESrilatha Edupuganti
Srilatha Edupuganti
JSJianhua Sui
Jianhua Sui
PWPatrick Wilson
Patrick Wilson
The 2009 pandemic H1N1 influenza pandemic demonstrated the global health threat of reassortant influenza strains. Herein, we report a detailed analysis of plasmablast and monoclonal antibody responses induced by pandemic H1N1 infection in humans. Unlike antibodies elicited by annual influenza vaccinations, most neutralizing antibodies induced by pandemic H1N1 infection were broadly cross-reactive against epitopes in the hemagglutinin (HA) stalk and head domain of multiple influenza strains. The antibodies were from cells that had undergone extensive affinity maturation. Based on these observations, we postulate that the plasmablasts producing these broadly neutralizing antibodies were predominantly derived from activated memory B cells specific for epitopes conserved in several influenza strains. Consequently, most neutralizing antibodies were broadly reactive against divergent H1N1 and H5N1 influenza strains. This suggests that a pan-influenza vaccine may be possible, given the right immunogen. Antibodies generated potently protected and rescued mice from lethal challenge with pandemic H1N1 or antigenically distinct influenza strains, making them excellent therapeutic candidates.

1 November 2013 in Emerging Infectious Diseases
Verified
Journal Article
Open access
ZMZiad A. Memish
Ziad A. Memish
NMNischay Mishra
Nischay Mishra
KOKevin Olival
Kevin Olival
SFShamsudeen F. Fagbo
Shamsudeen F. Fagbo
VKVishal Kapoor
Vishal Kapoor
ILIan Lipkin
Ian Lipkin
The source of human infection with Middle East respiratory syndrome coronavirus remains unknown. Molecular investigation indicated that bats in Saudi Arabia are infected with several alphacoronaviruses and betacoronaviruses. Virus from 1 bat showed 100% nucleotide identity to virus from the human index case-patient. Bats might play a role in human infection.

6 March 2008 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
GPGustavo Palacios
Gustavo Palacios
JDJulian Druce
Julian Druce
LDLei Du
Lei Du
TTThomas Tran
Thomas Tran
CBChris Birch
Chris Birch
ILIan Lipkin
Ian Lipkin
Three patients who received visceral-organ transplants from a single donor on the same day died of a febrile illness 4 to 6 weeks after transplantation. Culture, polymerase-chain-reaction (PCR) and serologic assays, and oligonucleotide microarray analysis for a wide range of infectious agents were not informative.

13 February 2013 in JAMA
Verified
Journal Article
Open access
PDF file
PSPål Surén
Pål Surén
CRChristine Roth
Christine Roth
MBMichaeline Bresnahan
Michaeline Bresnahan
MHMargaretha Haugen
Margaretha Haugen
MHMady Hornig
Mady Hornig
CSCamilla Stoltenberg
Camilla Stoltenberg
Supplementation with folic acid around the time of conception reduces the risk of neural tube defects in children.1-7 This protective effect has led to mandatory fortification of flour with folic acid in several countries,8 and it is generally recommended that women planning to become pregnant take a daily supplement of folic acid starting 1 month before conception.8,9